TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10709884

Group type: EXPERIMENTAL
Intervention: Infant formula with 13 g l(‐1) of protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infant formula with 15 g l(‐1) of protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infant formula with 18/20 g l(‐1) of protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swedish weaning foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Italian weaning foods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All formula groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 8684510

Group type: EXPERIMENTAL
Intervention: Physostigmine capsules (up to 10 mg per day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Physostigmine patch (transdermal application)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Physostigmine (in open follow-up study)
Number of subjects: 35
Study: 1627368

Group type: EXPERIMENTAL
Intervention: 75 mg/m2 doxorubicin every 3 weeks for four courses (arm 1)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 25 mg/m2 weekly for 12 courses (arm 2)
Number of subjects: 59
Study: 6378118

Group type: EXPERIMENTAL
Intervention: Active dialysis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 24
Study: 31248744

Group type: EXPERIMENTAL
Intervention: Planning plus education intervention (n=52)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Education-only intervention (n=50)
Number of subjects: 102
Study: 29960876

Group type: EXPERIMENTAL
Intervention: SMART boost arm
Number of subjects: 60

Group type: COMPARATOR
Intervention: SIB-IMRT (control arm)
Number of subjects: 60
Study: 26463644

Group type: EXPERIMENTAL
Intervention: Specialist palliative care (SPC)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 513
Study: 25010107

Group type: EXPERIMENTAL
Intervention: Higher levels of self-efficacy
Number of subjects: 141
Study: 22895810

Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: L-carnitine (500 mg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Mg-L-carnitine (500 mg/day magnesium and 500 mg/day L-carnitine)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 133
Study: 19800827

Group type: EXPERIMENTAL
Intervention: Calculated based on desired final optimum thyroid mass value (m(f)=0.24 m(0)/U(0)) in GR2
Number of subjects: 97

Group type: COMPARATOR
Intervention: Calculated based on fixed absorbed dose of 400 Gy in GR3
Number of subjects: 97

Group type: COMPARATOR
Intervention: Calculated based on fixed absorbed dose of 100 Gy in GR1
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Average activity administered to GR2
Number of subjects: 97

Group type: COMPARATOR
Intervention: Average activity administered to GR3
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Thyroid absorbed dose in GR2
Number of subjects: 97

Group type: COMPARATOR
Intervention: Thyroid absorbed dose in GR3
Number of subjects: 97
Study: 18077922

Group type: EXPERIMENTAL
Intervention: Ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica
Number of subjects: 88

Group type: COMPARATOR
Intervention: Base cream (vehicle)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ointment containing Mahonia aquifolium, Viola tricolor and Centella asiatica (in cold and dry conditions)
Number of subjects: 88
Study: 15665010

Group type: EXPERIMENTAL
Intervention: 150 IU recFSH plus 75 IU recLH (lutropin alpha)
Number of subjects: 127

Group type: COMPARATOR
Intervention: 150 IU recFSH (follitropin alpha)
Number of subjects: 127
Study: 12399266

Group type: EXPERIMENTAL
Intervention: Betaine supplementation (6 g/d)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 42
Study: 9933276

Group type: EXPERIMENTAL
Intervention: Detection of MCA territory hypodensity on hyperacute CT scans
Number of subjects: 50
Study: 7755536

Group type: EXPERIMENTAL
Intervention: Eight-session telephone behavior therapy program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Telephone behavior therapy
Number of subjects: 42
Study: 2406658

Group type: EXPERIMENTAL
Intervention: Dilapan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laminaria
Number of subjects: 0
Study: 6270809

Group type: EXPERIMENTAL
Intervention: Nicergoline (2.5 mg i.v.)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30990131

Group type: EXPERIMENTAL
Intervention: Process oriented goal setting
Number of subjects: 41

Group type: COMPARATOR
Intervention: Outcome oriented goal setting
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups during retention trials
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Process group on the 10th retention trial
Number of subjects: 41
Study: 28315010

Group type: EXPERIMENTAL
Intervention: Meperidine with benzodiazepine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fentanyl with benzodiazepine
Number of subjects: 40
Study: 26413928

Group type: EXPERIMENTAL
Intervention: Remote group (RG)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 300
Study: 24157401

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal vasopressin (AVP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) and vasopressin (AVP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22513499

Group type: EXPERIMENTAL
Intervention: Early occlusal loading at 1 week after surgery
Number of subjects: 12

Group type: COMPARATOR
Intervention: Early occlusal loading at 6 weeks after surgery
Number of subjects: 12
Study: 19459090

Group type: EXPERIMENTAL
Intervention: Self-hypnosis (self-help)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 58
Study: 17117373

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Weighted regression model
Number of subjects: 523
Study: 16011816

Group type: EXPERIMENTAL
Intervention: Vardenafil 5 mg, 10 mg, or 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12088804

Group type: EXPERIMENTAL
Intervention: Propofol (n = 30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thiopental (n = 30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both anesthetics
Number of subjects: 60
Study: 9860409

Group type: EXPERIMENTAL
Intervention: Oral norfloxacin 400 mg/12 h for 7 days
Number of subjects: 56

Group type: COMPARATOR
Intervention: Norfloxacin plus intravenous ceftriaxone 2 g daily during the first 3 days of admission
Number of subjects: 56

Group type: COMPARATOR
Intervention: Norfloxacin plus intravenous ceftriaxone
Number of subjects: 56
Study: 8593198

Group type: EXPERIMENTAL
Intervention: Stabilized stannous fluoride dentifrice (SnF2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control dentifrice (placebo)
Number of subjects: 0
Study: 2762182

Group type: EXPERIMENTAL
Intervention: APF foam (0.9 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: APF gel (4 g)
Number of subjects: 20
Study: 1155873

Group type: EXPERIMENTAL
Intervention: Continuous agar oral administration, 125 mg before each of the seven formula feedings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discontinuous agar administration, 250 mg before three of the seven formula feedings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous phototherapy for 96 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with no prophylaxis
Number of subjects: 0
Study: 31736406

Group type: EXPERIMENTAL
Intervention: Concurrent training group (CTG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 23
Study: 30195198

Group type: EXPERIMENTAL
Intervention: Edentulous participants (0 teeth)
Number of subjects: 20548

Group type: EXPERIMENTAL
Intervention: Participants with 1-9 teeth
Number of subjects: 20548

Group type: COMPARATOR
Intervention: Participants with 20 or more teeth
Number of subjects: 20548
Study: 28458115

Group type: EXPERIMENTAL
Intervention: Pregnenolone treatment (n=6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo treatment (n=5)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Healthy controls (n=4)
Number of subjects: 11
Study: 25504992

Group type: EXPERIMENTAL
Intervention: Helmet
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mask
Number of subjects: 80
Study: 24159904

Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL) curriculum for brief intervention skills
Number of subjects: 56

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 56
Study: 20948432

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 300 mg/2 weeks
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 150 mg/2 weeks
Number of subjects: 1065

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 405 mg/4 weeks
Number of subjects: 1065
Study: 18441720

Group type: EXPERIMENTAL
Intervention: High-oxalate food consumption
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Estimated oxalate intake
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Consumption of various food items high in oxalate content
Number of subjects: 484
Study: 17315804

Group type: EXPERIMENTAL
Intervention: Oral-health workshop
Number of subjects: 830
Study: 14531866

Group type: EXPERIMENTAL
Intervention: Emollient containing skin-related lipids (Locobase Repair)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Petrolatum-based emollient
Number of subjects: 30
Study: 11822223

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 6 days
Number of subjects: 192

Group type: COMPARATOR
Intervention: Azithromycin 1 g once daily (single dose)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg b.i.d. for 14 days
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg b.i.d. for 7 days
Number of subjects: 192
Study: 9762946

Group type: EXPERIMENTAL
Intervention: Oral glutamine (2 g amino acid/M2/dose twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (glycine)
Number of subjects: 24
Study: 7924856

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1% eyedrops
Number of subjects: 64

Group type: COMPARATOR
Intervention: Flurbiprofen 0.03% eyedrops
Number of subjects: 64
Study: 3150273

Group type: EXPERIMENTAL
Intervention: FLM 5011
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional immunosuppressive therapy
Number of subjects: 0
Study: 31507095

Group type: EXPERIMENTAL
Intervention: Motivational counseling sessions and tailored text messages
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual lifestyle (Control)
Number of subjects: 150
Study: 30376410

Group type: EXPERIMENTAL
Intervention: Irradiated group
Number of subjects: 60
Study: 28419204

Group type: EXPERIMENTAL
Intervention: Sabin‐IPV high dose
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Sabin‐IPV medium dose
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Sabin‐IPV low dose
Number of subjects: 500

Group type: COMPARATOR
Intervention: Trivalent oral polio vaccine
Number of subjects: 500

Group type: COMPARATOR
Intervention: Salk strain‐based IPV
Number of subjects: 500
Study: 25923490

Group type: EXPERIMENTAL
Intervention: Haloperidol (low-dose)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Normal pre-surgery QTc-duration
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Prolonged pre-surgery QTc-duration
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: PD-QTc (n=8)
Number of subjects: 89
Study: 22236169

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (CH) intracanal medication for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study: 22133165

Group type: EXPERIMENTAL
Intervention: Non-pharmacological multicomponent group therapy (MAKS) - motor stimulation, practice in activities of daily living, cognitive stimulation, conducted in groups of ten patients for 2 hours, 6 days a week for 12 months.
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group receiving usual care.
Number of subjects: 98
Study: 19758253

Group type: EXPERIMENTAL
Intervention: Dentifrice slurry containing 5,000 ppm F
Number of subjects: 28

Group type: COMPARATOR
Intervention: Water solutions containing 1.5% SLS
Number of subjects: 28
Study: 16766439

Group type: EXPERIMENTAL
Intervention: Survey of attitudes and beliefs about hypnosis among college students.
Number of subjects: 280
Study: 15249273

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 21

Group type: COMPARATOR
Intervention: Galantamine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rivastigmine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: Donepezil (high-dose)
Number of subjects: 21
Study: 11549648

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9526696

Group type: EXPERIMENTAL
Intervention: Asthma education program
Number of subjects: 241
Study: 30326124

Group type: EXPERIMENTAL
Intervention: Low-dose theophylline (200 mg once or twice per day)
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1578
Study: 27238068

Group type: EXPERIMENTAL
Intervention: Brief interpersonal psychotherapy for mothers (IPT-MOMS)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Brief supportive psychotherapy (BSP)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Both interventions (IPT-MOMS and BSP)
Number of subjects: 168
Study: 25622742

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine + Ropivacaine (RD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl + Ropivacaine (RF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal Saline + Ropivacaine (RN)
Number of subjects: 60
Study: 22831283

Group type: EXPERIMENTAL
Intervention: Microbial diversity at day 7 (measured by AluI)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Microbial diversity at day 7 (measured by Sau96I)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Microbial diversity
Number of subjects: 98
Study: 19476479

Group type: COMPARATOR
Intervention: BIAsp 30 b.i.d.
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: BIAsp 50 t.i.d.
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: BIAsp 70 t.i.d.
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: BIAsp 50 and BIAsp 30 b.i.d.
Number of subjects: 600
Study: 16928705

Group type: EXPERIMENTAL
Intervention: Therapeutic CPAP (10.7 cm H(2)O)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Subtherapeutic CPAP (4 cm H(2)O)
Number of subjects: 28
Study: 15219522

Group type: EXPERIMENTAL
Intervention: Extended-release niacin 1000 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Extended-release niacin 1500 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Extended-release niacin 2000 mg
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Extended-release niacin 3000 mg
Number of subjects: 432
Study: 11285986

Group type: EXPERIMENTAL
Intervention: hCG administration with oocyte collection intervals of 33-41 hours
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: hCG administration
Number of subjects: 533
Study: 9676345

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg b.i.d.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Theophylline (500 mg b.i.d.)
Number of subjects: 8
Study: 7929712

Group type: EXPERIMENTAL
Intervention: Head-injured patients (HI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 40
Study: 3209607

Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX) - 4 doses for 2 days
Number of subjects: 422

Group type: COMPARATOR
Intervention: Benzylpenicillin combined with cloxacillin (BPC) - 6 doses for 3 days
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Cefotaxime with additional antibiotics for fever (CTX-ADD)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Benzylpenicillin combined with cloxacillin with additional antibiotics for fever (BPC-ADD)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX) or CTX-ADD
Number of subjects: 422

Group type: COMPARATOR
Intervention: Benzylpenicillin combined with cloxacillin (BPC) or BPC-ADD
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX)
Number of subjects: 422
Study: 30642737

Group type: EXPERIMENTAL
Intervention: Probiotic plus selenium (200 μg/day selenium + 2 × 10^9 CFU/day of Lactobacillus acidophilus, Bifidobacterium bifidum, and Bifidobacterium longum)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Probiotic plus selenium
Number of subjects: 79

Group type: COMPARATOR
Intervention: Selenium (200 μg/day)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 28315596

Group type: EXPERIMENTAL
Intervention: Strengthening exercises for hip and trunk muscles (three weekly sessions for eight weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual activities (Control group)
Number of subjects: 34
Study: 25562195

Group type: EXPERIMENTAL
Intervention: Yerba mate tea (5 g/day) for 6 weeks
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo (5 g/day) for 6 weeks
Number of subjects: 142
Study: 23165981

Group type: EXPERIMENTAL
Intervention: Multidisciplinary care from a movement disorders specialist, PD nurses, and social worker
Number of subjects: 122
Study: 21999374

Group type: EXPERIMENTAL
Intervention: Autologous stem cells (ASC) injection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional compression sleeve therapy (CST)
Number of subjects: 20
Study: 18181136

Group type: EXPERIMENTAL
Intervention: Focus groups
Number of subjects: 10
Study: 17130417

Group type: COMPARATOR
Intervention: Placebo group from the clinical phase III US Insulin‐like Growth Factor‐I Trial
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Database group of ALS patients
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo group from the clinical phase III trial
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Cox analysis for both groups
Number of subjects: 207
Study: 15276488

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopy (group A; n = 46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Axillary thoracotomy (group B; n = 44)
Number of subjects: 90
Study: 11775033

Group type: EXPERIMENTAL
Intervention: Early vocational intervention consisting of sociomedical examination, multidisciplinary assessment, and individual sociomedical rehabilitation plans.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Early vocational intervention
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 201
Study: 9269013

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated titanium plasma-sprayed implants
Number of subjects: 65

Group type: COMPARATOR
Intervention: Titanium plasma-sprayed implants
Number of subjects: 65
Study: 8305165

Group type: EXPERIMENTAL
Intervention: 1.0 micrograms/kg x min nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 100 mumol/min magnesium
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.0 micrograms/kg x min nifedipine plus 100 mumol/min magnesium
Number of subjects: 8

Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 8
Study: 3545647

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Angiotensin II (ANG II) infusion
Number of subjects: 22
Study: 31311239

Group type: EXPERIMENTAL
Intervention: Reactive Initiation Training (RIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Shuttle Run (SR)
Number of subjects: 20
Study: 28055025

Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing (FEES)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Videofluoroscopic swallowing study (VFSS)
Number of subjects: 25
Study: 26115159

Group type: EXPERIMENTAL
Intervention: Ankaferd blood stopper (ABS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 50
Study: 24046411

Group type: EXPERIMENTAL
Intervention: 20 nmol of c-di-GMP administered intramuscularly (IM) in conjunction with penicillin G for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group treated with saline and penicillin G
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gavage treatment with 20 nmol of c-di-GMP in conjunction with penicillin G
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM treatment with c-di-GMP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 22141214

Group type: EXPERIMENTAL
Intervention: Parental presence during anesthetic induction
Number of subjects: 40

Group type: COMPARATOR
Intervention: No parental presence during anesthetic induction
Number of subjects: 40
Study: 19674132

Group type: COMPARATOR
Intervention: Standard triple therapy plus bismuth subcitrate (lansoprazole 30 mg b.i.d., amoxicillin 1000 mg b.i.d., clarithromycin 500 mg b.i.d., bismuth subcitrate 300 mg q.i.d. for 14 days)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Standard triple therapy plus bismuth subcitrate and vitamins C (500 mg b.i.d.) and E (200 IU b.i.d. for 30 days)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 17175645

Group type: EXPERIMENTAL
Intervention: Shengmai injection (40 ml) with 250 ml 50 g/L glucose solution for 3 days, 1 time per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group with 290 ml 50 g/L glucose injection liquid for 3 days, 1 time per day
Number of subjects: 20
Study: 15608587

Group type: EXPERIMENTAL
Intervention: 60-minute motivational/skills-building HIV risk reduction counseling intervention
Number of subjects: 228

Group type: COMPARATOR
Intervention: 20-minute HIV information/education session
Number of subjects: 228
Study: 11353932

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion (10 ng/kg/min for 1 hour)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nitric oxide (NO) inhalation (20 ppm for 1 hour)
Number of subjects: 10
Study: 9398951

Group type: EXPERIMENTAL
Intervention: 0.05 mg.kg‐1 rocuronium + 1.5 mg.kg‐1 succinylcholine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal saline followed by 1.0 mg.kg‐1 succinylcholine
Number of subjects: 75